Edesa Biotech (EDSA) Asset Utilization Ratio (2015 - 2021)
Edesa Biotech (EDSA) posted Asset Utilization Ratio of 0.0 for Q2 2021, down 99.62% sequentially from 0.01 in Q1 2021, and down 99.94% YoY from 0.04 in Q2 2020.
Edesa Biotech (EDSA) Asset Utilization Ratio (2015 - 2021) Analysis & Trends
Edesa Biotech has reported Asset Utilization Ratio for 7 years, with the latest figure at 0.0 in Q2 2021.
- Quarterly Asset Utilization Ratio fell 99.94% year-over-year to 0.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was 0.0 (down 99.94% YoY) and the FY2020 annual result came in at 0.04, down 15.03% from the prior year.
- Asset Utilization Ratio eased to 0.0 in Q2 2021 per EDSA's latest filing, from 0.01 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.15 in Q2 2017 and troughed at 0.01 in Q1 2018.
- A 5-year average of 0.03 and a median of 0.01 in 2018 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2018 and 2020: Asset Utilization Ratio tumbled 107.87% in 2018, then surged 64958.15% in 2020.
- Over 5 years, Asset Utilization Ratio stood at 0.01 in 2017, then surged by 184.63% to 0.01 in 2018, then surged by 137.47% to 0.02 in 2019, then increased by 4.75% to 0.02 in 2020, then plunged by 99.88% to 0.0 in 2021.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.0, 0.01, and 0.02 for Q2 2021, Q1 2021, and Q4 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.90 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.54 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.13 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.13 |
| 10 | Edesa Biotech | 43.15 Mn | 43.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.01 |
| Dec 31, 2020 | 0.02 |
| Sep 30, 2020 | 0.03 |
| Jun 30, 2020 | 0.04 |
| Mar 31, 2020 | 0.03 |
| Dec 31, 2019 | 0.02 |
| Jun 30, 2019 | 0.00 |
| Dec 31, 2018 | 0.01 |
| Sep 30, 2018 | 0.01 |
| Jun 30, 2018 | -0.01 |
| Mar 31, 2018 | -0.01 |
| Dec 31, 2017 | -0.01 |
| Sep 30, 2017 | 0.01 |
| Jun 30, 2017 | 0.15 |
| Mar 31, 2017 | 0.15 |
| Dec 31, 2016 | 0.15 |
| Sep 30, 2016 | 0.21 |
| Jun 30, 2016 | 0.08 |
| Mar 31, 2016 | 0.07 |